Aurinia Pharmaceuticals Inc. (AUPH)
NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous Close | 5.01 |
| Open | 5.10 |
| Bid | 5.08 x 500 |
| Ask | 5.11 x 500 |
| Day's Range | 4.98 - 5.18 |
| 52 Week Range | 4.71 - 12.43 |
| Volume | |
| Avg. Volume | 2,096,363 |
| Market Cap | 736.106M |
| Beta (5Y Monthly) | 1.38 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Business Wire
The U.S. Food & Drug Administration (FDA) Approves Updated LUPKYNIS® (voclosporin) Label to include Long-Term Data from the AURORA Clinical Program
ROCKVILLE, Md. & EDMONTON, Alberta, April 30, 2024--The U.S. Food & Drug Administration (FDA) Approves Updated LUPKYNIS® (voclosporin) Label to include Long-Term Data from the AURORA Clinical Program
- Business Wire
UPDATE: New Aurinia Presentation Details at the 2024 Bloom Burton & Co. Healthcare Investor Conference
ROCKVILLE, Md. & EDMONTON, Alberta, April 16, 2024--UPDATE: New Aurinia Presentation Details at the 2024 Bloom Burton & Co. Healthcare Investor Conference
- Business Wire
Aurinia Pharmaceuticals to Release First Quarter Financial and Operational Results on May 2, 2024
ROCKVILLE, Md. & EDMONTON, Alberta, April 15, 2024--Aurinia Pharmaceuticals to Release First Quarter Financial and Operational Results on May 2, 2024
© 2024 Yahoo. All rights reserved.